Physician profile
Brian Kent Barton
NPI 1598890493
$1,418.28
in general payments reported to CMS, 2019-2025
10 companies · $243 in 2025
The $243 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $269 · 2020: $263 · 2021: $120 · 2022: $147 · 2023: $254 · 2024: $122 · 2025: $243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $619.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $619.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $243.06 | 2025 | |
| Sun Pharmaceutical Industries INC. | $234.09 | 2023-2024 | Cequa |
| Glaukos Corporation | $229.09 | 2019-2020 | |
| Carl Zeiss Meditec, INC. | $159.32 | 2020 | |
| Johnson & Johnson Vision Care, INC. | $136.75 | 2021-2023 | Acuvue |
| Dompe US, INC. | $124.99 | 2023 | Oxervate |
| Allergan, INC. | $113.17 | 2022 | |
| Optos, INC. | $80.64 | 2019 | |
| Coopervision INC. | $62.53 | 2019-2022 | |
| Alcon Vision LLC | $34.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Barton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.